Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Uniqure
Uniqure
(QURE)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Glybera
Alipogene tiparvovec
2012-10-25
Hyperlipoproteinemia type i
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Alipogene tiparvovec
hyperlipoproteinemia type i
,
hyperlipidemias
,
hyperlipoproteinemias
Mycophenolate sodium
autoimmune diseases
Orgotein
wounds and injuries
,
reperfusion injury
,
myocardial reperfusion injury
Alfacalcidol
alpha-mannosidosis
,
mannosidase deficiency diseases
Bevifimod
amenorrhea
,
fertility
,
hepatorenal syndrome
,
nocturia
,
anovulation
,
laron syndrome
,
pituitary dwarfism
,
female infertility
,
hypogonadism
,
diabetes mellitus
,
neurogenic diabetes insipidus
,
postpartum hemorrhage
,
carcinoma
,
infertility
,
prostatic neoplasms
,
nocturnal enuresis
,
syndrome
,
cardiovascular diseases
,
polycystic ovary syndrome
,
cesarean section
,
obstetric delivery
,
aortic valve stenosis
,
eye diseases
,
growth disorders
Lotamilast
ovarian neoplasms
,
fallopian tube neoplasms
,
carcinosarcoma
,
hereditary breast and ovarian cancer syndrome
Remetinostat
uveal neoplasms
,
uveal melanoma
Usistapide
uveal neoplasms
,
uveal melanoma
Solumedrol
adrenal insufficiency
,
cushing syndrome
,
adrenocortical hyperfunction
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use